Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer’s disease

By Roher Alex E.   Maarouf Chera L.   Sue Lucia I.   Hu Yiran   Wilson Jeffrey   Beach Thomas G.  

Biomarkers, Vol. 14, Iss. 7, 2009-11 ,pp. : 493-501

Informa Healthcare

Access to resources Recommend Favorite

Combined measurement of PEDF, haptoglobin and tau in cerebrospinal fluid improves the diagnostic discrimination between alzheimer’’s disease and other dementias

By Abraham Jean-Daniel   Calvayrac-Pawlowski Sophie   Cobo Sandra   Salvetat Nicolas   Vicat Guillaume   Molina Laurence   Touchon Jacques   Michel Bernard-Franççois   Molina Franck   Verdier Jean-Michel   Fareh Jeannette   Mourton-Gilles Chantal  

Biomarkers, Vol. 16, Iss. 2, 2011-03 ,pp. : 161-171

Informa Healthcare

Access to resources Recommend Favorite

Cryogenic solid state NMR studies of fibrils of the Alzheimer’s disease amyloid-β peptide: perspectives for DNP

By Lopez del Amo Juan-Miguel   Schneider Dennis   Loquet Antoine   Lange Adam   Reif Bernd  

Journal of Biomolecular NMR, Vol. 56, Iss. 4, 2013-08 ,pp. : 359-363

Springer Publishing Company

Access to resources Recommend Favorite

Correlation between Changes of FDG-PET Findings and those of Mini- Mental Status Examination Scores in Patients with Moderate Alzheimer’s Disease: Usefulness of Stereotactic Extraction Estimation

By  

Current Molecular Imaging, Vol. 3, Iss. 1, 2014-03 ,pp. : 10-14

Bentham Science Publishers

Access to resources Recommend Favorite

MicroRNA in Alzheimer's disease: an exploratory study in brain, cerebrospinal fluid and plasma

By Bekris Lynn M.  

Biomarkers, Vol. 18, Iss. 5, 2013-08 ,pp. : 455-466

Informa Healthcare

Access to resources Recommend Favorite